Hotspot


Archive | 1999

NOVEL TRIAZOLO[4,5-d]PYRIMIDINE COMPOUNDS

Simon Guile; David Hardern; Brian Springthorpe; Paul Willis


Archive | 1999

Triazolo(4,5-d)pyrimidine compounds

David Hardem; Anthony Ingall; Brian Springthorpe; Paul Willis; Simon Guile


Journal of Medicinal Chemistry | 2007

Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.

Simon Guile; John Raymond Bantick; Martin Cooper; David Keith Donald; Christine Eyssade; Anthony Howard Ingall; Richard J. Lewis; Barrie Martin; Rukhsana T. Mohammed; Timothy J. Potter; Rachel Heulwen Reynolds; Stephen St-Gallay; Andrew D. Wright


Archive | 2002

Thienopyrimidinediones and their use in the modulation of autoimmune disease

Rachel Heulwen Reynolds; Anthony Howard Ingall; Rukhsana Tasneem Loughborough Rasul; Simon Guile; Martin Cooper


Archive | 1998

1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists

Simon Guile; Anthony Ingall; Brian Springthorpe; Paul Willis


Organic Letters | 2001

Formal intramolecular [5 + 2] photocycloaddition reactions of maleimides: A novel approach to the CDE ring skeleton of (-)-cephalotaxine

Kevin I. Booker-Milburn; Leo F. Dudin; Christopher E. Anson; Simon Guile


Archive | 2008

Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition

David Hardern; Anthony Ingall; Brian Springthorpe; Paul Willis; Simon Guile


Archive | 2000

[1,2,3]-triazolo[4,5-d] pyrimidine compounds

Simon Guile; Brian Springthorpe


Archive | 2008

A quinoline derivative acting as a p2x7-receptor antagonist

Simon Guile; Toby Thompson


Archive | 2008

Quinoline derivatives 057

Simon Guile; Toby Thompson

Researchain Logo
Decentralizing Knowledge